Citation: | WANG Yongqiang, YE Ting, LIU Jinbo. DNA Methylation Profile of Tumor Suppressor Genes in Diagnosis of Primary Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1330-1334. DOI: 10.3971/j.issn.1000-8578.2014.12.017 |
[1] |
Das PM, Singal R. DNA methylation and cancer[J]. J Clin Oncol, 20 04, 22: 4632-42.
|
[2] |
Li Z, Chen B, Wu Y, et al. Genetic and epigenetic silencing of the beclin1 gene in sporadic breast tumors[J]. BMC Cancer, 2010, 10: 98.
|
[3] |
Endoh H, Yatabe Y, Shimizu S, et al. RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication[J]. Int J Cancer, 2003, 106(1): 45-51.
|
[4] |
Abbaszadegan MR, Moaven O, Sima HR, et al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer[J]. World J Gastroenterol, 2008, 14(13): 2055-60.
|
[5] |
Kato K, Iida S, Uetake H, et al. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer[J]. Int J Cancer, 2008, 122(3): 603-8.
|
[6] |
Ni J, Chen HY, Cao N, et al. Effects of folate with different oxidative states on genomic DNA methylation in human lymphoblast cell line[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41 (03): 256-9. [倪娟, 陈海燕, 曹能, 等. 不同氧化态叶酸对人成 淋巴细胞系基因组DNA甲基化水平的影响[J]. 肿瘤防治研究, 20 14, 41(03): 256-9.]
|
[7] |
De Zhu J. The altered DNA methylation pattern and its implications in liver cancer[J]. Cell Res, 2005, 15(4): 272-80.
|
[8] |
Li Z, Chen B, Wu Y, et al. Genetic and epigenetic silencing of the Beclin1 gene in sporadic breast tumors[J]. BMC Cancer, 2010, 10 : 98.
|
[9] |
Zhang XF, Yin ZF, Wang K, et al. Changes of serum alphafetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(6): 618-23.
|
[10] |
Fei BJ, Huang ZH, Hua D, et al. Clinical significance of methylation of plasma Ras-association domain family 1A gene in the molecular diagnosis of hepatocellular carcinoma[J]. Zhong Liu, 2011, 31(8): 742-7.[费伯健, 黄朝晖, 华东, 等. 血浆Ras相关 区域家族蛋白1A基因甲基化在肝细胞癌分子诊断中的价值[J]. 肿瘤, 2011, 31(8): 742-7.]
|
[11] |
Qiu XQ, Chen G, Yu HP, et al. Detection of RASSF1A promoter hypermethylation in plasma of patients with primary hepatocellular carcinoma and its clinical significance[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2009, 17(1): 90-3. [仇小强, 陈罡 ,余红平, 等. 肝癌患 者血液RASSF1A基因甲基化的检测及其临床意义[J]. 世界华人 消化杂志, 2009, 17(1): 90-3.]
|
[12] |
Yu CH. SPSS and statistic analysis[M]. Beijing: Publishing House of Electronics Industry, 2007: 356-408. [宇传华. SPSS与统计分 析[M] 北京: 电子工业出版社, 2007: 356-408.]
|
[13] |
Zhou XJ, Xue WJ, Qin L, et al. Epigenetic inactivation and clinical significance of tumor suppressor gene RASSF1A in hepatocellular carcinoma[J]. Jiangsu Yi Yao, 2007, 33(1): 24-7. [周晓俊, 薛万江, 秦磊, 等. 原发性肝癌中RASSF1A基因表达失活及其临床意义 [J] 江苏医药, 2007, 33(1): 24-7.]
|